BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
170 hedge funds and large institutions have $1.98B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2019 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
30% more funds holding
Funds holding: 131 → 170 (+39)
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
Holders
170
Holding in Top 10
12
Calls
$57.2M
Puts
$24.9M
Top Buyers
| 1 | +$43.6M | |
| 2 | +$24M | |
| 3 | +$23.2M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$18.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$16.9M |
Top Sellers
| 1 | -$97.4M | |
| 2 | -$67.3M | |
| 3 | -$19.8M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$19.5M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$17.4M |